Clinical Trial Update: Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating autologous lung stem cell transplantation for safety and efficacy in idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• autologous lung stem cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1, Phase 2 | Status: COMPLETED